Then, we compared the proliferation and angiogenic potentials between the endothelia derived from ADPKD- and control-iPSCs using immunostaining with a proliferation marker Ki67 and tube formation assay, respectively, finding no significant differences in either assay (Figure S9b–d)37. This evidence concerns the gene MKI67 and autosomal dominant polycystic kidney disease.